In conclusion, our results point to alterations in the immune systems of CCA and HCC patients that converge in a decreased ability to develop a proinflammatory response, observed here by the diminished percentage of circulating T cells expressing IFN-γ and/or IL-17. The gene discussed is IL17A; the disease is cholangiocarcinoma.